NanoVibronix (NAOV) Revenue & Revenue Breakdown


OverviewOwnershipFinancialsChart

NanoVibronix Revenue Highlights


Latest Revenue (Y)

$2.28M

Latest Revenue (Q)

$376.00K

Main Geography (Y)

UNITED STATES

NanoVibronix Revenue by Period


NanoVibronix Revenue by Year

DateRevenueChange
2023-12-31$2.28M203.59%
2022-12-31$752.00K-55.63%
2021-12-31$1.70M172.07%
2020-12-31$623.00K17.55%
2019-12-31$530.00K66.67%
2018-12-31$318.00K33.05%
2017-12-31$239.00K4.37%
2016-12-31$229.00K55.78%
2015-12-31$147.00K-27.59%
2014-12-31$203.00K-3.79%
2013-12-31$211.00K27.11%
2012-12-31$166.00K76.60%
2011-12-31$94.00K-

NanoVibronix generated $2.28M in revenue during NA 2023, up 203.59% compared to the previous quarter, and up 717.92% compared to the same period a year ago.

NanoVibronix Revenue by Quarter

DateRevenueChange
2024-09-30$376.00K-53.98%
2024-06-30$817.00K-11.29%
2024-03-31$921.00K-21.75%
2023-12-31$1.18M156.99%
2023-09-30$458.00K55.78%
2023-06-30$294.00K-16.95%
2023-03-31$354.00K-447.06%
2022-12-31$-102.00K-205.15%
2022-09-30$97.00K-80.00%
2022-06-30$485.00K78.31%
2022-03-31$272.00K-64.90%
2021-12-31$775.00K55.31%
2021-09-30$499.00K56.92%
2021-06-30$318.00K208.74%
2021-03-31$103.00K14.44%
2020-12-31$90.00K-40.00%
2020-09-30$150.00K-44.24%
2020-06-30$269.00K135.96%
2020-03-31$114.00K31.03%
2019-12-31$87.00K-13.86%
2019-09-30$101.00K-61.60%
2019-06-30$263.00K232.91%
2019-03-31$79.00K46.30%
2018-12-31$54.00K-
2018-09-30$54.00K-59.09%
2018-06-30$132.00K71.43%
2018-03-31$77.00K10.00%
2017-12-31$70.00K7.69%
2017-09-30$65.00K25.00%
2017-06-30$52.00K-
2017-03-31$52.00K6.12%
2016-12-31$49.00K-19.67%
2016-09-30$61.00K-1.61%
2016-06-30$62.00K8.77%
2016-03-31$57.00K46.15%
2015-12-31$39.00K-2.50%
2015-09-30$40.00K2.56%
2015-06-30$39.00K34.48%
2015-03-31$29.00K-44.23%
2014-12-31$52.00K108.00%
2014-09-30$25.00K-60.94%
2014-06-30$64.00K3.23%
2014-03-31$62.00K675.00%
2013-12-31$8.00K-84.00%
2013-09-30$50.00K47.06%
2013-03-31$34.00K-40.35%
2012-12-31$57.00K42.50%
2012-09-30$40.00K-

NanoVibronix generated $376.00K in revenue during Q3 2024, up -53.98% compared to the previous quarter, and up 127.89% compared to the same period a year ago.

NanoVibronix Revenue Breakdown


NanoVibronix Revenue Breakdown by Country

Annual Revenue by Country

CountryDec 23Dec 22Dec 21Dec 20Dec 19
UNITED STATES$2.16B$710.00K$1.63M--
AUSTRALIA$19.00M$9.00K---
Europe$101.00M$25.00K$18.00K$147.00K$168.00K
ISRAEL$1.00M$5.00K---
INDIA-$3.00K---
Other Country-$5.00K---
Other country--$45.00K--
India---$1.00K$12.00K
United States---$467.00K$331.00K
Other---$5.00K$5.00K
Israel---$3.00K$14.00K

NanoVibronix's latest annual revenue breakdown by geography, as of Dec 23: UNITED STATES (94.70%), Europe (4.42%), AUSTRALIA (0.83%), and ISRAEL (0.04%).

Quarterly Revenue by Country

CountryJun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Mar 20Sep 19Jun 19Mar 19
UNITED STATES$794.00K$905.00M$2.16B$445.00K$282.00K$309.00K$-118.00K$90.00K$476.00K$231.00K$753.00K$490.00K$292.00K-------
Other$15.00K$23.00K------------------
AUSTRALIA$8.00K$4.00M$18.98M$2.00K$13.00K---------------
Other Country-$12.00M$11.00K$12.00K$12.00K---------------
Europe--$100.98M$19.00K$12.00K$6.00K$7.00K$3.00K$4.00K$10.00K$1.00K$10.00K$17.00K$3.00K-$151.00K$10.00K---
Asia-----$1.00K$1.00K$9.00K------------
NEW ZEALAND-------$1.00K$3.00K$2.00K$3.00K$3.00K--------
ISRAEL----------$1.00K$2.00K$1.00K-------
CANADA------------$12.00K-------
New Zealand-------------$9.00K------
United States-------------$92.00K$76.00K$130.00K$110.00K$101.00K$90.00K$68.00K
Israel-------------$1.00K-$1.00K$1.00K-$12.00K$1.00K
India--------------$-1.00K$2.00K$8.00K---
Canada--------------------
Canada 21------------------$2.00K-

NanoVibronix's latest quarterly revenue breakdown by geography, as of Jun 24: UNITED STATES (97.18%), Other (1.84%), and AUSTRALIA (0.98%).

NanoVibronix Peer Comparison by Revenue


TickerCompanyLast Year RevenueLast Quarter Revenue
SSKNSTRATA Skin Sciences$33.36M$8.44M
RPIDRapid Micro Biosystems$22.52M$7.60M
HSCSHeart Test Laboratories$18.60M-
VVOSVivos Therapeutics$13.80M$3.86M
NUWENuwellis$8.86M$2.37M
RSLSReShape Lifesciences$8.68M$2.29M
SINTSintx$2.63M$799.00K
NAOVNanoVibronix$2.28M$376.00K
TIVCTivic Health Systems$1.18M$126.00K
BJDXBluejay Diagnostics--
BBLGBone Biologics--
BMRABiomerica-$1.81M

NAOV Revenue FAQ


What is NanoVibronix’s yearly revenue?

NanoVibronix's yearly revenue for 2023 was $2.28M, representing an increase of 203.59% compared to 2022. The company's yearly revenue for 2022 was $752K, representing a decrease of -55.63% compared to 2021. NAOV's yearly revenue for 2021 was $1.7M, representing an increase of 172.07% compared to 2020.

What is NanoVibronix’s quarterly revenue?

NanoVibronix's quarterly revenue for Q3 2024 was $376K, a -53.98% decrease from the previous quarter (Q2 2024), and a -17.90% decrease year-over-year (Q3 2023). The company's quarterly revenue for Q2 2024 was $817K, a -11.29% decrease from the previous quarter (Q1 2024), and a 177.89% increase year-over-year (Q2 2023). NAOV's quarterly revenue for Q1 2024 was $921K, a -21.75% decrease from the previous quarter (Q4 2023), and a 160.17% increase year-over-year (Q1 2023).

What is NanoVibronix’s revenue growth rate?

NanoVibronix's revenue growth rate for the last 3 years (2021-2023) was 34.69%, and for the last 5 years (2019-2023) was 330.75%.